Pharma stocks have seen significant movement over the past few months, but with the market turning selective, how should investors position themselves? Avani Bhatt, Senior Vice President, Equity Derivatives Research at JM Financial, shares her insights on navigating the sector. She highlights the performance of Pharma BEEs, which rallied from ₹18 to ₹24.5 post-May, and provides her expert recommendations for selective stock investments. Her preferred picks include Dr. Reddy's, Divi's Laboratorie